Want to see HK:2877 full AI Analyst Report?
Total Valuation
China Shineway Pharmaceutical Group Limited has a market cap or net worth of HK$5.62B. The enterprise value is -HK$2.78B.
Market CapHK$5.62B
Enterprise Value-HK$2.78B
Share Statistics
China Shineway Pharmaceutical Group Limited has 827,000,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding827,000,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
China Shineway Pharmaceutical Group Limited’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 5.93%.
Return on Equity (ROE)0.12
Return on Assets (ROA)0.09
Return on Invested Capital (ROIC)5.93%
Return on Capital Employed (ROCE)0.08
Revenue Per Employee1.18M
Profits Per Employee477.89K
Employee Count2,656
Asset Turnover0.29
Inventory Turnover1.26
Valuation Ratios
The current PE Ratio of China Shineway Pharmaceutical Group Limited is 6.0. China Shineway Pharmaceutical Group Limited’s PEG ratio is 0.45.
PE Ratio6.0
PS Ratio1.86
PB Ratio0.72
Price to FCF5.99
Price to Operating Cash Flow4.49
PEG Ratio0.45
Income Statement
In the last 12 months, China Shineway Pharmaceutical Group Limited had revenue of 3.14B and earned 949.95M in profits. Earnings per share was 1.26.
Revenue3.14B
Gross Profit2.27B
Operating Income682.07M
Pretax Income1.27B
Net Income949.95M
EBITDA752.95M
Earnings Per Share (EPS)1.26
Cash Flow
In the last 12 months, operating cash flow was 1.07B and capital expenditures -174.98M, giving a free cash flow of 891.41M billion.
Operating Cash Flow1.07B
Free Cash Flow891.41M
Free Cash Flow per Share1.08
Dividends & Yields
China Shineway Pharmaceutical Group Limited pays an annual dividend of HK$0.995, resulting in a dividend yield of 16.82%
Dividend Per ShareHK$0.995
Dividend Yield16.82%
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.44
52-Week Price Change17.38%
50-Day Moving Average6.78
200-Day Moving Average6.77
Relative Strength Index (RSI)63.52
Average Volume (3m)2.18M
Important Dates
China Shineway Pharmaceutical Group Limited upcoming earnings date is Mar 30, 2027, TBA (Confirmed).
Last Earnings DateAug 27, 2026
Next Earnings DateMar 30, 2027
Ex-Dividend Date―
Financial Position
China Shineway Pharmaceutical Group Limited as a current ratio of 3.71, with Debt / Equity ratio of 3.81%
Current Ratio3.71
Quick Ratio3.43
Debt to Market Cap0.06
Net Debt to EBITDA-9.11
Interest Coverage Ratio119.98
Taxes
In the past 12 months, China Shineway Pharmaceutical Group Limited has paid 319.32M in taxes.
Income Tax319.32M
Effective Tax Rate0.25
Enterprise Valuation
China Shineway Pharmaceutical Group Limited EV to EBITDA ratio is -1.36, with an EV/FCF ratio of -1.05.
EV to Sales-0.33
EV to EBITDA-1.36
EV to Free Cash Flow-1.05
EV to Operating Cash Flow-0.87
Balance Sheet
China Shineway Pharmaceutical Group Limited has HK$7.54B in cash and marketable securities with HK$312.23M in debt, giving a net cash position of HK$7.22B billion.
Cash & Marketable SecuritiesHK$7.54B
Total DebtHK$312.23M
Net CashHK$7.22B
Net Cash Per ShareHK$8.74
Tangible Book Value Per ShareHK$10.44
Margins
Gross margin is 71.27%, with operating margin of 21.75%, and net profit margin of 30.30%.
Gross Margin71.27%
Operating Margin21.75%
Pretax Margin40.48%
Net Profit Margin30.30%
EBITDA Margin24.01%
EBIT Margin21.75%
Analyst Forecast
The average price target for China Shineway Pharmaceutical Group Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-17.74%
EPS Growth Forecast1.12%